Via Google Translate so may contain translation errors That writes the Belgian business daily De Tijd Wednesday. Or the IPO actually continues, according to the newspaper depends mainly on the results of a large-scale RA study conducted midkapper Galapagos. Those results are expected to be announced in mid-April.
CEO Onno van de Stolpe, Galapagos made his ambitions known at a conference of KBC Securities, which was attended by thirty investors. Van de Stolpe Wednesday was not available for an explanation, but a company spokesman told the business daily that the IPO "one of the options." Time also writes that pharmaceutical company AbbVie be interested to take over Galapagos.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.